AVITA Medical Inc (RCEL)
8.08
-0.49
(-5.72%)
USD |
NASDAQ |
Apr 25, 12:08
AVITA Medical Price to Book Value: 4.234 for April 25, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 24, 2024 | 4.491 |
| April 23, 2024 | 4.706 |
| April 22, 2024 | 4.480 |
| April 19, 2024 | 4.528 |
| April 18, 2024 | 4.648 |
| April 17, 2024 | 4.915 |
| April 16, 2024 | 5.083 |
| April 15, 2024 | 4.957 |
| April 12, 2024 | 5.177 |
| April 11, 2024 | 5.424 |
| April 10, 2024 | 7.567 |
| April 09, 2024 | 7.845 |
| April 08, 2024 | 7.928 |
| April 05, 2024 | 8.065 |
| April 04, 2024 | 7.923 |
| April 03, 2024 | 7.934 |
| April 02, 2024 | 7.976 |
| April 01, 2024 | 8.149 |
| March 28, 2024 | 8.400 |
| March 27, 2024 | 8.646 |
| March 26, 2024 | 8.379 |
| March 25, 2024 | 8.314 |
| March 22, 2024 | 8.222 |
| March 21, 2024 | 8.453 |
| March 20, 2024 | 8.463 |
| Date | Value |
|---|---|
| March 19, 2024 | 8.405 |
| March 18, 2024 | 8.295 |
| March 15, 2024 | 8.610 |
| March 14, 2024 | 8.730 |
| March 13, 2024 | 8.956 |
| March 12, 2024 | 8.908 |
| March 11, 2024 | 8.615 |
| March 08, 2024 | 8.977 |
| March 07, 2024 | 8.914 |
| March 06, 2024 | 8.620 |
| March 05, 2024 | 8.966 |
| March 04, 2024 | 9.191 |
| March 01, 2024 | 9.464 |
| February 29, 2024 | 9.501 |
| February 28, 2024 | 8.840 |
| February 27, 2024 | 9.595 |
| February 26, 2024 | 9.590 |
| February 23, 2024 | 8.961 |
| February 22, 2024 | 8.914 |
| February 21, 2024 | 9.118 |
| February 20, 2024 | 9.212 |
| February 16, 2024 | 9.16 |
| February 15, 2024 | 9.265 |
| February 14, 2024 | 9.076 |
| February 13, 2024 | 8.882 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.174
Minimum
Jun 17 2022
269.57
Maximum
Feb 19 2020
42.18
Average
5.403
Median
Price to Book Value Benchmarks
| Cerus Corp | 5.647 |
| Elutia Inc | -- |
| Perspective Therapeutics Inc | 12.49 |
| Xtant Medical Holdings Inc | 2.333 |
| Asensus Surgical Inc | 1.967 |
Price to Book Value Related Metrics
| PS Ratio | 4.082 |
| PEG Ratio | -0.1872 |
| Price | 8.08 |
| Earnings Yield | -17.33% |
| Market Cap | 207.71M |
| PEGY Ratio | -0.1872 |